← Back to Clinical Trials
Recruiting NCT05169762
Feminizing Treatment in Transgender Women and Non-binary Persons
Trial Parameters
Condition Transgenderism
Sponsor Odense University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex MALE
Min Age 18 Years
Max Age N/A
Start Date 2022-02-01
Completion 2035-09-01
Interventions
standard treatment
Brief Summary
Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.
Eligibility Criteria
Inclusion Criteria: * assigned male at birth and eligeble for gender affirming feminizing treatment Exclusion Criteria: none \-